Showing 1581-1590 of 9758 results for "".
The Tax Cuts and Jobs Act: What You Need to Know
https://practicaldermatology.com/topics/practice-management/the-tax-cuts-and-jobs-act-what-you-need-to-know/20529/An overview of changes that may impact dermatologists and their practices.Honey for Recurrent Minor Aphthous Ulcers; Foundations for an Online Initiative
https://practicaldermatology.com/youngmd-connect/resident-resource-center/honey-for-recurrent-minor-aphthous-ulcers-foundations-for-an-online-initiative/20658/Is Biopsy Effective for BCC on the Head and Neck?; Ask an Expert: Wound Care and Healing
https://practicaldermatology.com/youngmd-connect/resident-resource-center/is-biopsy-effective-for-bcc-on-the-head-and-neck-ask-an-expert-wound-care-and-healing/21141/Physician Spotlight: Amy McMichael, MD
https://practicaldermatology.com/columns/physician-spotlight/physician-spotlight-amy-mcmichael-md/21178/Case Report: First Reported Case of Facial Rash After Dupilumab Therapy; Call for Abstracts
https://practicaldermatology.com/youngmd-connect/resident-resource-center/case-report-first-reported-case-of-facial-rash-after-dupilumab-therapy-call-for-abstracts/20499/The Role of Oral Contraceptive Pills in the Acne Treatment Plan
https://practicaldermatology.com/topics/general-topics/the-role-of-oral-contraceptive-pills-in-the-acne-treatment-plan/20483/When OCPs are the right choice for patients.Warts and All: A Treatment Update for Verruca Vulgaris
https://practicaldermatology.com/topics/general-topics/warts-and-all-a-treatment-update-for-verruca-vulgaris/21451/A Growing Biologics Armamentarium for Psoriasis and Atopic Dermatitis
https://practicaldermatology.com/topics/psoriasis/a-growing-biologics-armamentarium-for-psoriasis-and-atopic-dermatitis/20660/An overview of effective and safe treatment options that continue to come to market to target these chronic conditions.Clinical Data on Switching to Upadacitinib
https://practicaldermatology.com/series/updates-atopic-dermatitis/clinical-data-on-switching-to-upadacitinib/36534/Clinical investigator Christopher Bunick, MD, PhD, discusses results from the LEVEL UP trial among patients who switched from dupilumab to upadacitinib for atopic dermatitis.Journal Club: Does the Epithelial Barrier Hypothesis Explain the Increase In Allergy, Autoimmunity, and Other Chronic Conditions?
https://practicaldermatology.com/columns/research-reports/journal-club-does-the-epithelial-barrier-hypothesis-explain-the-increase-in-allergy-autoimmunity-and-other-chronic-conditions/24040/